Reading time: 1 minuteThe acquisition of amaxa is in line with Lonza’s strategy of growing its life-science platform. amaxa is a premium supplier to the cell discovery market with leading edge, proprietary technologies in well defined market niches of transfection systems. The deal further strengthens Lonza’s position as a worldwide leader in cell discovery by integrating this unique, proprietary technology into its portfolio and by continuing to develop the company’s activities.
Commencing today, Lonza will start integrating amaxa and its approximately 160 employees into the existing structure of the company.
Editor's note: Image rights belong to the respective publisher.
Source: Lonza, Press release